TechFlex is dedicated to assisting startups in the Series A and Seed money stages to achieve their objectives through a structured and supportive framework. Our approach focuses on providing tailored solutions that address the unique challenges faced by early-stage companies.
TechFlex is the catalyst for success in the medical device industry, offering comprehensive support to growing companies. With expertise spanning from initial concept to market entry, TechFlex provides tailored solutions, cutting-edge technologies, and regulatory guidance.
A new AI-based technology developed at Washington University School of Medicine in St. Louis analyzes mammograms to provide a more accurate prediction of an individual’s risk of developing breast cancer over the next five years.
Read the full article at: www.newswise.com
